ELON Meme Coin Early Holder Sees 600x Gain, Entered Position at $17k Market Cap
BlockBeats News, January 30, according to GMGN monitoring, the address ranked second on the Solana ecosystem Meme coin ELON holding list (8nxf…) is one of the early investors. When the market cap of ELON was only about $17,600, this address invested around $593 to build its position. With the price increase, its total holding profit has now risen to about $200,000, with a return on investment of 600x.
Previously, when the market cap of ELON was around $1.65 million, this address sold nearly half of its holdings, realizing some early profits. Currently, it still holds about 1.62% of the circulating supply and has not sold further. The current market cap of this Meme coin is reported to be $11 million, with a current price of about $0.011.
BlockBeats reminds users that Meme coin trading is highly volatile, heavily dependent on market sentiment and speculative hype, with no real value or use case. Investors should be aware of the risks.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.
TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).
Crypto prices
More
